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Dur,rr,,rt. ,v,>r,,, Cnnrbrto 
rereiwd hleh d&~ntr&enour LhkmimlytiE L~rapy with 
sLrwfokina_w in addition lo ancioplasty. Similar followw 
were similar, but multivswl angioplnsty was mire ctnn- 
man in the eleclive group (13 ws~s 48, p = 0.02). The 
Emergent percutaneous translummal coronary angioplasty, 
with or without thrombolytic therapy. is an ct&tivc method 
far acbtcving myocardial reperfusian and relieving coronary 
SLenOslt during evol+ :acule myocsrdial infarction (I-15). 
The long-term risk of recurrent symptoms and angiographic 
rcstenosis in palistda discharged from the hospital afler 
successful emergent coronary angioplasty for acute myocar- 
dial infarction. however, has not been described. Previous 
studies i!-3.8) have consisted primarily of clinical follow-up. 
with only small numbers of palien& having repeat coronary 
angiography after hospital discharge. In contrast. the resten- 
ohis rates and factors related to rcstcnosis after elective 
coronary angiopla>ly have been characterized in multiple 
gro;lps of patients i I&25). No previous study has compared 
thr restenosis rates after emergent and clcctive angioplasty 
in patients treated concurrcnlly. Accordingly, the purpose of 
ihe present study was II dclermine the long-term clinical and 
angiographic res~nos;s rate prospectively in a consecutive 
group of paGents who had accenfid emergent coronq 
angiopbaty for acute myocardwl mfarcimn. ,md 10 ~ompax 
these findings wthrhore from aconcurrent groupofpatxnt~ 
who had ,eccea,fui coronq vngiopiilcty on an siecwe 
basis. 
successfui emergeto coronary angioplarty for Ihe treatment 
of evolving acute myocadial mferaion and patients wth a 
successful elective coronary angioplasty from January I iz 
December 31, 1985 were prospecinely and consecutively 
enrolled in a program of 6 month outpatwnt recatherenca- 
tion to assess the incidence of resteoos~s. All p.wemr 
discharged from the hospital wdh successful ang~opla\ty 
procedures were potential candidates for restudy with the 
following exclusion criteria: I) death. 2) coronary bypass 
surgery for multivessel disease. 3) cerebrovascular accident 
before follow-up, or 4) medical contraindication 10 repeat 
angiogmphy (renal failure, severe ~yrtcmic ilIne>\ or 
bleeding diathesis). Successful coronary angioplarty WPE 
defined as an immediate postanpioplasty stenosis of rSlJ% 
luminal diameter narrowing detenined visually by a panel 
of at least three experienced angiographers. Patients having 
multivessel aogioplasty with successful dilation of at least 
one vessel but failure I” another vessel were also eligible for 
study. Patients having a failed aogioplarty procedure or 
clinical and aogiographx evidence of reuccluhion at the 
rngioplasty site or sites before hospital discharge were 
excluded. Failed angioplasty was defined as a residual 
sicnosi~ of >5WA luminal diameter narrowing at the angio- 
plasty site immediately after the procedure. Krocciuwx~ W,G 
defined as recurrat symptoms coupled with angmgraphi- 
tally documented evidence of a recurrent stenosis of >50% 
at a previously successful angioplasty site before ho\piM 
discharge. 
Thrombolytic therapy. In addition to emergent coronary 
angioplasty. I.5 million units of intravcnou~ streptokxse 
WE given to I50 patients and I50 mg of intravenous recom 
binant tissue-type plasminogen activator to I I patisntr in the 
acute myocardial infarction group. SW pattents had coronmy 
angioplasty without pnor thrombalytic therapy Enrollmrm 
criteria included the following: 1) continuous chest pair 
consistent with myocardtal infarction of 56 duration accorm 
panied by ST segment e!evation ~2 mot in two or more 
electrocardiographic (KG) leads. or 2) mtermntent l”stut- 
tering”) chest pain of 6 to 24 h duration with both pan and 
ST segment elevation on arrival. Pauents meeting the entry 
criteria did not receive tbrombolytic therapy if they had any 
of the following cmtraindication~: 1) recent history of gar- 
trointestinal bleeding. stroke, major wgery or trauma Iln- 
eluding prolcnped cardmpulmonary reru~at~on); 21 history 
of’_lezdmg dlathesis: II prolifcretive diabetic retmopathy: or 
4) re;x uncontrolled hypertenrion. 
Cnvrb ior cmqrr,, coronay un&~losty. These m- 
I-!II?P~ A total or subtotal 1272%) occlusion of the inlarcl- 
related anery with a lexoo wdable ior a-diu&tj- in lhe 
subJectwe judgmen: of the attending cardiolagM. Patients 
whose thrombased anery was successfully reperfused with 
thrombolytic thenpy but who had infarct vessel or lesions 
unsudable for aneioplasty (left main coronary artery steno- 
sis ~everc diffuse disease or residual stenosis ~50% after 
thrombolyslsl were excluded. During the study period. 46 
parienn were excluded from angioplasty because of rhe 
f~+lowmg reasons: left main coronary artery diceaw (5 
r,atientc). <were multwessel disease (2i patients). unsmtable 
leGon morphology 113 patients). insignificant lestons (SW+ 
stenosis) 16 patients) and patient refusal (I patient). 
Ekcnw ong~oplasry grwp. This group mcluded a cow 
waive wnes of paoents wh,, had been selected for coro- 
nary angmplarty became rf angiagraphic evidence of 
rigmficant 8coronary lesions (a75J luminal narrowing). 
Symptoms A the time of angi,)plasty m this groop are listed 
in T&e I and include no synptoms or atypical chest pain 
112%;. stable angina Wb). ~rogrenswe angina 152%) hod 
uns!nNe angina (IS%!. 
AnMrms,ho,ic ~Aw,rp!. Patientr in hoth the acute myo- 
cardial infaction and elcctivc angioplasty groups were rou- 
tinely gwen ltl.oo(1 U hcparin intravenously at the start of the 
angioplacly procedure. Hcparin infusion was maintained for 
224 h in all p&ot~ with myocardial infarction but was not 
routinely administered after the procedure in Ihe electwe 
group Pa:ients in both groups received aspirin (325 mdday) 
and dipyridamolc (75 mg three times a day) from the time of 
angioplasty umd hosp!tal dicchargc. All patients were dis- 
charged oo treatment with aspirin, dipyridamolr and a 
c&ium chanwl blocking agent. 
Comnwy angioplasi? prwedure. Each procedure :.a 
performed by a team of two senior statTcardiologistr and a 
cardmlogy fellow. Coronary angioplasty was performed us- 
mc an BF thin wall auldinr catheter and a low Qrofile balloon 
catheter. D,larions-wererepe~led es often .; necessary to 
achieve a rcsldual stenosis of ~50% luminal diameter reduc- 
tion. Results during the procedure were assessed with high 
resolution videofluoroscopy and final rcsuits were deter- 
mined from a rcvicw of Ihe cineangiograms. In the acute 
myocardml mfxction group. only lhc infxct-related artery 
was dilated in the acute setting; lesions in other vessels that 
were believed to be QrOgnOstiCntty important were ap- 
proached later with either angioplasty or surgery on an 
elective basis. Surgical backup was available for each patient 
undergong angioplasty. 
Followq program. All eligible piltients discharged from 
the hospital with a successful coronary angioplasry proce. 
dure were asked to return for an outpatient 6 month recath- 
elerization. Before cardiac catheterization, all patients gave 
a history, took a physical examination. routine laboratory 
tests and an ECG. Outpatient coronary angiography and left 
ventriculography were performed using the Judkins tech- 
nique with 5F or 6F catheters. Patients were kept at bed rest 
fo: ? I: Se: !he ow~dure and the,, were oat of bed for 30 
min before dmhkgc. 
Definition sf clinical variables. In addition to basic demo- 
graptlic information for each patient, data were Qrospec- 
lively collected for selected patient- and angiographic- 
related clinical variables to compare the baseline 
charactenstu of the myocardial infarction and elective 
angioplaary groups. The clinical variables chosen for analy 
sis were those that have been demonstrated or postulated to 
have an effect on the resttenosis raw age. sex, dunticm of 
symptomatic coronuy disease. symQtoms at the time of 
angioplasly and at follow-up. historv of diabetes mellitus. 
number of diseased vessels with r7j% stenosis at baseline 
angiography. location and number oflesions receivingangio- 
plasty. multivessel angioplasty. intnnnl dissection immcdi- 
ately after ang~oplasty and Ume from angioplably to outpa- 
tient follow-up. 
change m New York Heart Association functional class for 
a6 weeks); 3) progressive angisa (incrcasc in frequency. 
severity or duration of angina1 symptoms a6 weeks before 
angioplacty): 41 unstable angina (angina1 symptoms requiring 
coronary care unit admission and intravenous nitroglycerin); 
and 5) acute myocardial infarction (as defined previously). A 
history of diabetes mellitus was defined as a previous history 
of elevated fasting blood glucose. 
Wfinition of angiographie rertenosir. The luminal diame- 
ter at the site (or sites) of the previously successful angio- 
plasty procedure was determined for each patient after 
follow-up angiography by a panel of at least three experi- 
enced angiographers. Coronary luminal diameter narrowing 
was graded on an ordinal scale (that is, 0%. <25%, 25%, 
50%. 75%, 95%. 100%) as previously described (26). The 
coronary angiographic methods used in this study have been 
validated in a previous angiographic-pathologic study (27). 
Angiographic restenosis was defined as a >50% luminal 
diameter narrowing at the prrviously successful angioplasty 
site, and thus was znalyzed as a binary outcome variable 
(that is, restenosis Qresenliabsent) for each patient. The 
restenoris rates for the myocardial infarction and elective 
angioplasty groups were compared using all patients in the 
analysis and also, because of the higher tnuitivewt angio- 
plasty rate in the elective group, using orly patients in both 
groups with single w.sel coronary angioplasty. 
Statistteal analysis. Continuous data were summarized 
with means and standard deviations. Categorical data wre 
summarized with percentages. Group comparisons were 
made using the chi-square test or Fisher’s exact test for 
categorical data and the I test for continuous measure data. 
Results 
Clinical outcome of acute myoeardial infaretbm and elec. 
live coronary aogiupbasty groups. During the ,tudy. a tote: of 
167 consecutive patients were treated with emerg:nt core- 
nary angioplasty for evolving acute myoewdial infarction 
(I50 also with streptokinase and I I also with recombinant 
tissue pl;lsminogen activator) (Fig. I). Seventysix (46%) of 
these oe.ients were inelieible for lone-term follow-uo ansi- 
ograpiy because of f&d angioplas;y (n = 28). early L- 
hospital reocclusion (n = 2t), death (n = 171. interverdnq 
coronary bypass surgery for multivessel disease (n = 7). 
stroke (r = I) or medical contraindication to repeat angiog. 
raphy (n = 2). The remaining 91 patients (54%) were eligible 
for the study and, of these, 19 patients (87%) returned for 
outpatient follow-up angiography. 
During the SWIW period, (I focal of 257 consecurivr 
polienfs anderwenr coronoty ongioplnq on on elecrive 
bosis.(Fig. 2). Twenty-nine (II%) of these patients were 
ineligible for study because of failed angioplasty (n = IO). 
early reocclusion (n = 5). death (n = I), inWz!ing core- 
nary bypass surgery for multivessel disease (r, = 3). stroke 
01 = 3) or medical conrraindication IO repeat anglography 
01 = 7). The remaining 228 patients 189%) wre eligible for 
follow-up and. of these. 206 palientc (90%) returned for 
outpatient angiography. 
Comparison of rhe clinical oumxne~ for IhP myocardi,,l 
infarcfion and elective onpioplasry ~rottpr shows a slgndi- 
candy higher percentage of patients with myocardial infarc- 
lion ineligibleforfollow-up(~ = 64.3. p < U.UUUI). primanly 
because ofa higher rate of aog~opksty fadure (17 versus 4%. 
p = O.CCQ5). early reocclusion (13 versus 2%. p = U.oM)I) 
and death (IO versus 0.3%. p -z O.wOI) in th,s group. In 
addition. more patients in the infarction group than in the 
elective group required subsequent coronary bypass surgery 
for oiber coronary disease (4 vcrsos 1%. respectively. p = 
0.093). 
Baseline clinical profile of acute myocardial infarctkn and 
eketire conmay imgiqlasty groups (Tabk !I. The mean 
age. duration of symptomatic coronary disease. number of 
diseased ~vessek, history of diabetes mellitus and location 
and number of coronary angoplasty lesions were slmdar tar 
both groups. Baseline symptoms at the tune ofangioplasty in 
the elective group ranged from asymplomatic or atypical 
chert pam II?%1 to unsrable angma (15%) requiring urgcm 
angioplasty. Stable angiw was present m 21% and progre% 
Gve zmgma m 52% of the elective group. In the acute 
infarction group. angmal symptoms before Ihe lime of cmcr. 
gent angmplasty were precent in 31 patients (39%l with the 
remaining patients being asymptomatic before angiopla?ty. 
There were nonsignificant trends toward more left CIIC~I- 
Rex arkry ang~oplasly in th,: elective group and more m!!mal 
dirrecllon in the myocarc’ial infarction group. ‘There were 
s~gmficanlly more men in me myocardial infarction group (XI 
versus 63%. p = O.M)I). and multivessel angioplaty was 
performed more frcquemlv m the elective group (13 verse 
4%. p = 0.02). To adjust for the higher percenfage of 
muitwessel angioplasty in the elective group. the rcsleno~~ 
rates between Ihe two groups were compared both with and 
without paoents under&ng mullivessel angioplasty. 
Followw~ clinical or&k of acute myoeordkl infarction 
and ekctive’roronary &ioplasty groups (Fig. 3). The inter- 
val from coronary angioplasty to follow-up angiograpby was 
28 r 9 weeks for the infxction group and 30 t I I weeks for 
the elective group (p = NS). Fdlcen 119%l ofthe 79 patient> 
with myocardial infarction and 40 (19%) of the 206 patients in 
!hr eleElive group returned before the scheduled follow-ap 
date becaue of progressive symploms. Absence of symp- 
wns or arypnl chesl pain al the time of follow-up was more 
r ._. .L- :-L-^.:^_ .L^” i” .h. alll*,i,,l Inncnn,l.,” “.x#YS##1 ii. L,,L IIIIIII...~.. . ..“.. . ..- -.-_...- _..i._i ._.., 
group 179 versus 55%. re~pecrwely. p = U.WIl. At fol- 
low-up, stable, progressive or unstahk angina was presel. 
respectively. in 16. 4 and 0% of padems wah myocardial 
infarction and 26. 16 and 3% of those with elective an@“- 
pkwy (p = 0.002). One patient in each group returned with 
an evolvmp acute mywardial infarction. 
Angkgrnphk rerknwk rate for acute myacardial infarc- 
tien and rkctive coronary angioplasty growps (Fig. 4). The 
overall aoglographic restenoris rate af!rr hospital discharge 
was 19% for [he acute myocardial infarction group and 35% 
for the elccwe group (p = 0.006). Wbcn paoents with 
multivessel angioplasty were excluded from both groups. the 
restenosis rate* for the infarction and elective groups were 
19 and 33%. rcspcctively (p = 0.01). Taking into account 
early in-hospital rcoccluion. the combined rate of early 
r~occlubion plus late restcnosir was similar for patients in 
both the mfarctlon and electwe angioplasty groups 02 
wrsuc 37%. respectively. p = NSI. 
T/w reInlion oi rwlpro~s 10 angiojiruphic restenosk 
showed that. among patients who were asymptomatic or had 
atypical chw Pain at the time of followm. the aneioeraohic 
rcslenosis rate was 13% in the myocard&d infarciiong~oup 
and 25% in the elecdve angioplasty group. Symvtoms of 
angina at Mow-up were as frequen; ii patient; with angio- 
gnaphic restenosis ns wthout restenosis in both angioplasty 
8rooups. One patient in each group presented with a myocar- 
dial infarction after horpital discharge and before outpatient 
fo!lon-op. and in each the infarction was associated with an 
uxluded artery al the previous angmplasty site. 
Discussion 
The present study indicate5 that adverse clinical events 
are more common in the early postcoronary angioplasty 
period whereas late resleno~is is less common in patients 
undergamg emergent coronary angioplasty for acute myo- 
cardial mfarcuon lhan in palicnts undergoing elecwe angio- 
plasty. While 76 (46%) of tbc 167 patients with emergent 
angioplasty had failed angioplasly (17%). prehospital dis- 
charge reocclusion (13%). death ~iff~l, stroke (0.6%). inter- 
vening coronary bypass surgery for other coronary disease 
(4%) or medical contraindications to repeat angiography 
(1.M before tbc scheduled time of follow-up angiography, 
only 29 C 11%) of 257 pauentr with elective angioplasty had 
these outcomes (Fig. I and ?I. Most of rhe difference in early 
adverse cvcnts was due to a higher rate of primary angio- 
plasty failure (17 versus 4%). in-hospital reocclusion (13 
versus 2%) and death (IO versus 0.3%<in the emergent than 
in the elective group. In addition, there wan a trend lowa..d 
more coronary bypass surgery before follow-up in the emer- 
gent than in the elective group. However, of patients eligible 
and returning for late angiographic follow-up, symptoms of 
angina were less (20 versus 44%, p = 0.002) and the rate of 
angiographic restenosis lower (19 versus 35%, p = 0.006) in 
those with emergent than in those with elective angioplasty. 
If the early reocclusion and late restenosis rates were 
summed, the overall failure rates at the completion of 
follow-up were similar for both groups (32% emergent and 
37% elective). 
Primary coronary angiaplnsty failure and early reewlu- 
sion. The hiah rate of primary angkmlastv failure and earlv 
postangioplasty rec&sion i;l paiiehts Aeiving emergei 
angioplasty for coronary reperfusion in acute myocardial 
infarction has been reported in several previous studies 
(IA). but not with a comparison group of concurrently 
treated patients receiving elective angioplasty. primary cor- 
onary aqioplasty failure (<Xi% improvement in the steno- 
sis or a residual Stenosis of 275%) has been shown to occur 
in 0 to 35% of emergent angioplasty procedures for evolving 
myocardial infarction (I-15). Early angiographic reocclusion 
at the angioplasty site before hospital discharge OCCUR in 6 
to 31% of patients with initially successful procedures (t-6) 
(Table 2). The primary success rate of elective angioplasty 
has increased from 59% in the early reports of the National 
Heart, Lung, and Blood Institute (NHLBI) coronary angio- 
plasty regwy (28) to SO% in more recent series (D-32). 
The elective angioplasty success rate in our study was 96%. 
Early in-hospital reocclusion after elective coronary angiw 
plasty has been low (~5%) in recent studies using repeat 
angiography (29, 13). The present study extends these pee- 
vious observations by demonstrating that in patients treated 
over the same time penod wrh ~mtlar angioplaq wch- 
niques, emergent coronmy a*giopl;rciy with or withmu 
thrombolytic therapy for acute myowrdral infarction IC 
associated with higher early bilure and early reoccltxion 
rates than is elective sngiopla\ty. 
Although there is no clear explanation for the higher 
degree of failure and rcoccluGon after acute aoeioolaw of 
infarct-related lesions. several fxtora may be r&ms!‘ble. 
First, direct angioplasty of 1 totally obstrucad vexed (for 
example. after unsuccessful thrombolyar; does not allow lor 
an adequate twessment ofthr morphology of the underlymg 
stenosis and its suirahility for angioplasty. becood. P wbto- 
ml obstruction is often associated with a large thrombux that 
may be ditlicult to comoress bv balloon ddauon and mav 
embolize distally to occlude the mvolvcd vessel or a mayor 
side branch (34.35). Third, there may be a htgher propenrity. 
theoretically, to redevelop lbrombus at the tite of a prew 
ously thrombosed arterial segment as a result of perr~stent 
activation of platelets and residual deposits of fibrin that may 
have initiated the primary occlusion (36). Often. tbromboly- 
tic agents have not completely lyred thrombus from the 
active lesion by the time of emergent angioplasty. and these 
agents may be inadequate m some patients to prevent the 
continued activation of platelets and fibrinogen. resulting m 
rethrombosis. Fourth, recent evidence suggests that mtra- 
plaque hemorrhage may result from the performance of 
aogioplasty during the thrombolytic state. and may be sutli- 
cient to compromise the lumen 137). 
Lang-term clinical and aogiographic restenosis. The 
symptomatic profile at the time of follow-up angography m 
the present study shown a lower frequency of iecwreot 
angina (either stable, progressive or unstable) in patients 
treated with emergent coronary angioplasty for acute myo- 
cardial infarction than in those undergoing elective angio- 
plasty i20 versw 45%. p = 0.002) (Fig. 3). fievious studies 
(S-25) examinina the loon-term svmotomatic statue of oa- _ _ 
lients treated with coronary angioplasty on an elective basis 
have found that 40 to 50% of oatients develoo tvoical aneina 
pectoris ~6 months after the &edure. Of 231 &eots with 
elective coronary angioplasty followed up for r6 months, 
Levine Sal. (21) found that 169(43%) became symptomatic. 
Adowmhic restenosis was documented in 67% of I03 
symptomatic patients who consented to coronary angrogra- 
phy. Holmes :’ al. (16). in a report from the angioplasty 
registry of the National Heart, Lung, and Blood Institute. 
found that 45% of the 557 electwe patients who underwent 
follow-up angiography had chest pain judged to be definite or 
probable angina at a median follow-up interval of 188 days. 
In the sympto-natic patients, angiographic rewnos~s oc- 
curred in 56% as opposed to only 14% in asymptomat~ 
patients. No study of elective coronary angioplasty patients 
has reported B symptomatx rate at 6 months after angio. 
plasty as low as that found after emergent angioplasty for 
acute myocardial infarction in the present study. 
‘I-3.X) ITCtble 3). Meyer et ill. III reported on 6 month 
hollow-up of 17 pattents havmg wccc\sful primary coronary 
weprokmace for evolvmg myocardinl mfxction Thrsc pa- 
uent\ IIH%) had rcstcnow afkr hnrpit4 discharge: in two it 
wa< .ingmgrapbically documented and in one it was w- 
petted clmically as a result of reinfxction. Serruys et al. (8) 
Gbtamed chmcal and angiographtc data after a mew fol- 
low-up mterval of4 months in IS of 18 vatients !reatcd wth 
in~racoronary strcptokmarc and emergent coroaary angio- 
plasty for myocardial infarction. One patient (7%) developed 
rewrrent symptoms and had a previously dilated vessel that 
was not patent angiographrally at follow-up. Usmg a tech 
mque of emergent ang~oplasty and hew-in anticoagulation 
without thrombolytic agents, Hartzler et al. (3) reported late 
cbnical follow-up at a mean inerral of 6.5 momhs m 59 
pmirnl\ discharged from the hospital with patent. dilated 
coronary segments. Eleven patents C 19%) developed climcal 
and angio.graphic restenws. $ut routine follow-up angiogra- 
phv aai not performed in the absence of recurrent symp- 
tom$. The highest published rate of late rcslcnosis after 
emergent angioplasty for myocardial infzrction is reported 
by Gold ct al (2), who performed repeat angiography after a 
mean of 5.4 months in I I of I5 successfully treated patients 
and found a 45% rectenocic rate. 
TIP lonfi-rum wsrenosis n,te in fhr pmrnr srudy is ihe 
first to be reported afler Ihe combinalton of emergent coin- 
nary angtoplasty with htgh dose mtra~eoous streptakinase or 
recombmant tissue plasmmogcn actww~r therapy for acute 
m:,ocard!al mfarctton. The majority of patients l9O%J re- 
caved I .5 million units of intraver>oua rtreptokinase. and 6% 
received I50 mg of intravenous tissue plasminogen activator. 
Only six of our patients 14%) received emergent angtoplasty 
rithou! prior thrombolytic therapy. UGng a program of 
routine outpatient follow-up anpiugraphy. 86% of eligible 
clccl~vc angioplarty groups. ihc umc cnursc and pafhophy5- 
iolo%x basis for rrsleno\i\ dilTcrcd Cuncnl cvidencc points 
to inlima hyperplasia a< the must Imkeiy mechanism for late 
rerlenosis t3R.391. The time courw for r~st~nosis during 
hospilaliration in Ihe acute inlarclion group was IOU ahon to 
develop lhir degruc of crllular hypcrplaGa. The most likely 
explanauon ~nvolvc~ some comhmatlon of intii,nl dwcc- 
lion. plalclcl aggrcgalion wilh rccurent thromuorir or xule 
mtrsplaqoc hemorrhapr. Tbc rcason for the low long-term 
rcstenorir rate in the piments with myocardial infarction is 
unclear A mnior differroce hewcen Ihc myocardisl infarc- 
tion and elective anginpla~ly groups wa the use in the 
padents wrh infxclion of high do% lhromholylic agents at 
Ihe lime of coronary anwpla~y and Ihe tendency toward 
more prolonged hcparin anticoqulation. Despite B more 
active intrinic ihrombolic LMC al the angiopiasty site in the 
infarction group. Ihe use of high dose alreptokmase or tissue 
plasminogen actiwxor followed hy prolonged heparin infu- 
sion may have suppressed plalelet- and fibrin-mediated 
procesrcs that may he important mstgaton of long-term 
rcslenosis. 

